SPECIFICATIONS, STORAGE, AND DISTRIBUTION

规格、存储和分发

• 批准号: 2834309
• 负责人: LOUIS S. HARRIS
• 金额: $ 16.41万
• 依托单位: RESEARCH TRIANGLE INSTITUTE
• 依托单位国家: 美国
• 财政年份: 1996
• 资助国家: 美国
• 起止时间: 1996-09-30 至 2002-03-29
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2834309
• 关键词: SPECIFICATIONS; STORAGE; DISTRIBUTION

The contract shall provide NIDA's Medication Development Division with a centralized confidential repository of compounds for evaluation as potential treatment agents. The Contractor will serve as the central point for receipt of compounds, by MDD, from various compound submitters. Part of the Contractor's duties will be to analyze the compounds received for purity in order to insure that they are suitable for examination in MDD's testing paradigms for determining potential treatment agents for cocaine and opiate abuse. The Contractor will also "blind" the identity of the compounds to the testing sites. This will ensure that the test results will be free from any bias and preconceptions on the part of the sites.

合同应为NIDA的药物开发部门提供 用于评估化合物的集中机密存储库 潜在的治疗剂。 承包商将作为中央 从各种化合物提交器中收到化合物的点。 承包商的一部分职责是分析收到的化合物 为了确保它们适合检查 MDD的测试范例用于确定潜在的治疗剂 可卡因和鸦片滥用。 承包商还将“盲目”身份 测试位点的化合物。 这将确保测试 结果将不受任何偏见和先入之见。 站点。